Asymmetric Dimethylarginine (ADMA) and Cardiovascular Disease: Insights From Prospective Clinical Trials

Vascular Medicine - United Kingdom
doi 10.1177/1358836x0501000104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Asymmetric Dimethylarginine (ADMA) Accelerates Cell Senescence

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2005English

Homocysteine and Asymmetric Dimethylarginine (ADMA) in Neurological Diseases

JOURNAL OF ADVANCES IN CHEMISTRY
2017English

Asymmetric Dimethylarginine and Clinical Outcomes in Chronic Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2011English

Plasma Asymmetric Dimethylarginine (ADMA) Is Associated With Retinopathy in Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

Asymmetric Dimethylarginine (ADMA), Symmetric Dimethylarginine (SDMA) and L-Arginine in Patients With Arteriogenic and Non-Arteriogenic Erectile Dysfunction

International Journal of Andrology
2012English

Cardiovascular Risk Factors and the Concentration of Asymmetric Dimethylarginine

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Metabolism of Asymmetric Dimethylarginine and Its Clinical Significance

Turkish Journal of Biochemistry
BiochemistryClinical BiochemistryMolecular Biology
2012English

Asymmetric Dimethylarginine, the Promoter Factor of Cardiovascular Pathologies

Romanian Journal of Medical Practice
2019English

Asymmetric Dimethylarginine and Asthma

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy